Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Mitchell Ho is a Senior Investigator at the NIH and the Chief of the Antibody Therapy Section at NCI’s Laboratory of Molecular Biology. He is also the Chair of the Department of Biochemistry for the FAES Graduate School at the NIH. He received a B.S. from East China Normal University, a M.A. from San Francisco State University. After three years at DNAX Research Institute and Protein Design Labs as a research associate, he moved to the University of Illinois at Urbana-Champaign where he received a Ph.D. as a NIH/NIDA National Research Service Award predoctoral fellow. He completed a postdoctoral fellowship with Ira Pastan at the NCI. Dr. Ho has received many honors including the APAO Scientific Achievement Award, NIH DDIR Innovation Award, and NCI Director's Intramural Innovation Award. He is the Editor-in-Chief of Antibody Therapeutics.